Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Novelion to Cut an Unknown Number of Jobs in Restructuring

  • Post author:Sam
  • Post published:January 25, 2018
  • Post category:BioPharma

Novelion will slash an unknown number of jobs as it initiates "significant cost reduction plans." Source: BioSpace

Continue ReadingNovelion to Cut an Unknown Number of Jobs in Restructuring

AstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial

  • Post author:Sam
  • Post published:January 25, 2018
  • Post category:BioPharma

Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace

Continue ReadingAstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial

Incoming Novartis CEO, Bayer Leader Join President Trump for Private Dinner at Davos

  • Post author:Sam
  • Post published:January 25, 2018
  • Post category:BioPharma

During an international conference in Davos, Switzerland, President Donald Trump sat down with the leaders of several European life science companies to encourage more investment in the United States. Source:…

Continue ReadingIncoming Novartis CEO, Bayer Leader Join President Trump for Private Dinner at Davos

Ballsy Celgene Continues to Tread Carefully Into Neurosciences

  • Post author:Sam
  • Post published:January 25, 2018
  • Post category:BioPharma

The company made some bold moves this month in acquiring Juno and Impact Source: BioSpace

Continue ReadingBallsy Celgene Continues to Tread Carefully Into Neurosciences

Spectris Snaps Up Concept Life Sciences in £163M Deal

  • Post author:Sam
  • Post published:January 25, 2018
  • Post category:BioPharma

Concept will become a separate operating company within its Materials Analysis segment where it has strong synergies with the activities of Malvern Panalytical. Source: BioSpace

Continue ReadingSpectris Snaps Up Concept Life Sciences in £163M Deal

Rumor Alert: Allergan in Talks to Buy Out KaNDy Therapeutics in $400M Deal

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

KaNDy Therapeutics is a clinical-stage company that is focused on female sex-hormone related conditions. Source: BioSpace

Continue ReadingRumor Alert: Allergan in Talks to Buy Out KaNDy Therapeutics in $400M Deal

Outgoing Novartis CEO Hunts for His Next Big Challenge

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

Joseph Jimenez retires at the end of the month after eight years in the top job at Novartis. Source: BioSpace

Continue ReadingOutgoing Novartis CEO Hunts for His Next Big Challenge

Takeda Becomes the Latest to Notch an Alzheimer's Failure Under Its Belt

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

Another experimental Alzheimer's disease treatment has failed in a late-stage study. Source: BioSpace

Continue ReadingTakeda Becomes the Latest to Notch an Alzheimer's Failure Under Its Belt

Big Names in Biotech Seek $1M to Build Life-Size Statue of Legend Henri Termeer

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

The effort was announced last week by the Henri A. Termeer Tribute Committee. Source: BioSpace

Continue ReadingBig Names in Biotech Seek $1M to Build Life-Size Statue of Legend Henri Termeer

What You Need to Know About Immune-Onc Therapeutics

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California. Source: BioSpace

Continue ReadingWhat You Need to Know About Immune-Onc Therapeutics
  • Go to the previous page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.